These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 10955822

  • 1. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
    Coukos G, Makrigiannakis A, Kang EH, Rubin SC, Albelda SM, Molnar-Kimber KL.
    Clin Cancer Res; 2000 Aug; 6(8):3342-53. PubMed ID: 10955822
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.
    Jones NA, Turner J, McIlwrath AJ, Brown R, Dive C.
    Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207
    [Abstract] [Full Text] [Related]

  • 3. Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy.
    Coukos G, Makrigiannakis A, Montas S, Kaiser LR, Toyozumi T, Benjamin I, Albelda SM, Rubin SC, Molnar-Kimber KL.
    Cancer Gene Ther; 2000 Feb; 7(2):275-83. PubMed ID: 10770637
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL, Watson JM, Gehrig PA, Fowler WC, Haskill JS.
    Cancer Res; 1999 May 15; 59(10):2425-32. PubMed ID: 10344753
    [Abstract] [Full Text] [Related]

  • 5. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL.
    Cancer Gene Ther; 2000 Nov 15; 7(11):1469-80. PubMed ID: 11129289
    [Abstract] [Full Text] [Related]

  • 6. Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer.
    Xiang J, Gómez-Navarro J, Arafat W, Liu B, Barker SD, Alvarez RD, Siegal GP, Curiel DT.
    J Gene Med; 2000 Nov 15; 2(2):97-106. PubMed ID: 10809143
    [Abstract] [Full Text] [Related]

  • 7. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM, Hulscher TM, Schrier SM, van Houten VM, Pinedo HM, Boven E.
    Gynecol Oncol; 2002 Mar 15; 84(3):404-12. PubMed ID: 11855878
    [Abstract] [Full Text] [Related]

  • 8. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F.
    Cancer Res; 1996 Feb 01; 56(3):556-62. PubMed ID: 8564971
    [Abstract] [Full Text] [Related]

  • 9. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K, Li Z, Seth P, Cowan KH, Sinha BK.
    Oncol Res; 1997 Feb 01; 9(11-12):603-9. PubMed ID: 9563008
    [Abstract] [Full Text] [Related]

  • 10. Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer.
    Coukos G, Makrigiannakis A, Kang EH, Caparelli D, Benjamin I, Kaiser LR, Rubin SC, Albelda SM, Molnar-Kimber KL.
    Clin Cancer Res; 1999 Jun 01; 5(6):1523-37. PubMed ID: 10389942
    [Abstract] [Full Text] [Related]

  • 11. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.
    Eliopoulos AG, Kerr DJ, Herod J, Hodgkins L, Krajewski S, Reed JC, Young LS.
    Oncogene; 1995 Oct 05; 11(7):1217-28. PubMed ID: 7478541
    [Abstract] [Full Text] [Related]

  • 12. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS, Mills GB, Khokhar AR, Bast RC, Siddik ZH.
    Clin Cancer Res; 1999 Mar 05; 5(3):655-63. PubMed ID: 10100719
    [Abstract] [Full Text] [Related]

  • 13. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis.
    Vikhanskaya F, Vignati S, Beccaglia P, Ottoboni C, Russo P, D'Incalci M, Broggini M.
    Exp Cell Res; 1998 May 25; 241(1):96-101. PubMed ID: 9633517
    [Abstract] [Full Text] [Related]

  • 14. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR, Fletcher B, Page C, Hu C, Nunez G, Baker V.
    Gynecol Oncol; 1998 Sep 25; 70(3):398-403. PubMed ID: 9790794
    [Abstract] [Full Text] [Related]

  • 15. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.
    Raffo AJ, Kim AL, Fine RL.
    Oncogene; 2000 Dec 14; 19(54):6216-28. PubMed ID: 11175336
    [Abstract] [Full Text] [Related]

  • 16. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
    Concin N, Stimpfl M, Zeillinger C, Wolff U, Hefler L, Sedlak J, Leodolter S, Zeillinger R.
    Int J Oncol; 2003 Jan 14; 22(1):51-7. PubMed ID: 12469184
    [Abstract] [Full Text] [Related]

  • 17. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D, Nawa A, Tanino T, Goshima F, Luo CH, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Tsurumi T, Nishiyama Y, Kikkawa F.
    Cancer Lett; 2010 Feb 01; 288(1):17-27. PubMed ID: 19604626
    [Abstract] [Full Text] [Related]

  • 18. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
    Debernardis D, Siré EG, De Feudis P, Vikhanskaya F, Valenti M, Russo P, Parodi S, D'Incalci M, Broggini M.
    Cancer Res; 1997 Mar 01; 57(5):870-4. PubMed ID: 9041188
    [Abstract] [Full Text] [Related]

  • 19. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma.
    Herod JJ, Eliopoulos AG, Warwick J, Niedobitek G, Young LS, Kerr DJ.
    Cancer Res; 1996 May 01; 56(9):2178-84. PubMed ID: 8616869
    [Abstract] [Full Text] [Related]

  • 20. Radiation-induced apoptosis is not enhanced by expression of either p53 or BAX in SW626 ovarian cancer cells.
    Strobel T, Swanson L, Korsmeyer S, Cannistra SA.
    Oncogene; 1997 Jun 12; 14(23):2753-8. PubMed ID: 9190890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.